News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,389 Results
Type
Article (46167)
Company Profile (301)
Press Release (668921)
Section
Business (208969)
Career Advice (2230)
Deals (36287)
Drug Delivery (106)
Drug Development (82554)
Employer Resources (175)
FDA (16304)
Job Trends (15235)
News (352773)
Policy (33181)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (8)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2583)
Accelerated approval (2)
Adcomms (25)
Allergies (79)
Alliances (50892)
ALS (85)
Alzheimer's disease (1353)
Antibody-drug conjugate (ADC) (110)
Approvals (16279)
Artificial intelligence (232)
Autoimmune disease (14)
Automation (14)
Bankruptcy (369)
Best Places to Work (11737)
BIOSECURE Act (20)
Biosimilars (97)
Biotechnology (221)
Bladder cancer (52)
Brain cancer (26)
Breast cancer (241)
Cancer (1881)
Cardiovascular disease (148)
Career advice (1847)
Career pathing (30)
CAR-T (144)
Cell therapy (408)
Cervical cancer (14)
Clinical research (66659)
Collaboration (760)
Compensation (419)
Complete response letters (23)
COVID-19 (2624)
CRISPR (38)
C-suite (199)
Cystic fibrosis (100)
Data (1791)
Decentralized trials (2)
Denatured (19)
Depression (42)
Diabetes (228)
Diagnostics (6375)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (110)
Drug pricing (100)
Drug shortages (25)
Duchenne muscular dystrophy (72)
Earnings (86746)
Editorial (33)
Employer branding (21)
Employer resources (152)
Events (115176)
Executive appointments (625)
FDA (17321)
Featured Employer (51)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (669)
Gene editing (99)
Generative AI (21)
Gene therapy (291)
GLP-1 (698)
Government (4420)
Grass and pollen (4)
Guidances (47)
Healthcare (18937)
Huntington's disease (24)
IgA nephropathy (22)
Immunology and inflammation (101)
Indications (25)
Infectious disease (2749)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (74)
Interviews (355)
IPO (16794)
IRA (42)
Job creations (3930)
Job search strategy (1589)
Kidney cancer (10)
Labor market (30)
Layoffs (462)
Leadership (17)
Legal (8102)
Liver cancer (70)
Lung cancer (268)
Lymphoma (125)
Machine learning (2)
Management (61)
Manufacturing (269)
MASH (58)
Medical device (13341)
Medtech (13346)
Mergers & acquisitions (19915)
Metabolic disorders (617)
Multiple sclerosis (65)
NASH (18)
Neurodegenerative disease (80)
Neuropsychiatric disorders (27)
Neuroscience (1827)
NextGen: Class of 2025 (6672)
Non-profit (4525)
Northern California (2294)
Now hiring (37)
Obesity (340)
Opinion (241)
Ovarian cancer (62)
Pain (77)
Pancreatic cancer (74)
Parkinson's disease (128)
Partnered (18)
Patents (189)
Patient recruitment (87)
Peanut (46)
People (58666)
Pharmaceutical (69)
Pharmacy benefit managers (18)
Phase I (20859)
Phase II (29405)
Phase III (21778)
Pipeline (867)
Podcasts (63)
Policy (112)
Postmarket research (2592)
Preclinical (8796)
Press Release (72)
Prostate cancer (86)
Psychedelics (35)
Radiopharmaceuticals (246)
Rare diseases (366)
Real estate (6256)
Recruiting (67)
Regulatory (22525)
Reports (43)
Research institute (2370)
Resumes & cover letters (376)
Rett syndrome (3)
RNA editing (2)
RSV (39)
Schizophrenia (66)
Series A (121)
Series B (74)
Service/supplier (14)
Sickle cell disease (54)
Southern California (1979)
Special edition (15)
Sponsored (29)
Startups (3824)
State (2)
Stomach cancer (13)
Supply chain (60)
The Weekly (43)
United States (20347)
Vaccines (668)
Venture capitalists (37)
Webinars (12)
Weight loss (237)
Women's health (31)
Worklife (16)
Date
Today (118)
Last 7 days (625)
Last 30 days (3063)
Last 365 days (34752)
2025 (6595)
2024 (36004)
2023 (40711)
2022 (51900)
2021 (56370)
2020 (54694)
2019 (47157)
2018 (35607)
2017 (33141)
2016 (32600)
2015 (38468)
2014 (33848)
2013 (28963)
2012 (29453)
2011 (30123)
2010 (28203)
Location
Africa (800)
Alabama (48)
Alaska (7)
Arizona (218)
Arkansas (12)
Asia (39615)
Australia (6652)
California (5265)
Canada (1809)
China (439)
Colorado (240)
Connecticut (255)
Delaware (120)
Europe (86228)
Florida (777)
Georgia (181)
Idaho (57)
Illinois (496)
India (23)
Indiana (285)
Iowa (7)
Japan (133)
Kansas (103)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (811)
Massachusetts (4013)
Michigan (206)
Minnesota (363)
Mississippi (2)
Missouri (73)
Montana (30)
Nebraska (26)
Nevada (55)
New Hampshire (62)
New Jersey (1511)
New Mexico (29)
New York (1502)
North Carolina (918)
North Dakota (7)
Northern California (2294)
Ohio (182)
Oklahoma (13)
Oregon (33)
Pennsylvania (1197)
Puerto Rico (7)
Rhode Island (24)
South America (1187)
South Carolina (16)
South Dakota (1)
Southern California (1979)
Tennessee (87)
Texas (777)
Utah (163)
Virginia (125)
Washington D.C. (56)
Washington State (504)
West Virginia (3)
Wisconsin (48)
715,389 Results for "mesa biotech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025
January 17, 2025
·
1 min read
C-suite
Biotech a Bright Spot for Female Founders Amid DEI Pullback
A new Pitchbook report found $4.3 billion in funding to women-fronted biotech companies across 121 deals. The increase comes as sociopolitical headwinds slam into initiatives to support women and minorities.
March 6, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Mesa Labs Announces Third Quarter Results
February 4, 2025
·
18 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
Mesa Laboratories, Inc. will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 as previously communicated.
May 31, 2024
·
1 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
Mesa Laboratories, Inc. will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 31, 2024.
May 22, 2024
·
1 min read
Executive appointments
Women Leaders Decline in Biotech’s Era of ‘Proven Leadership’
Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a
BioSpace
analysis. This is happening in an era of biotech where new company founders are searching for CEOs with a track record.
February 5, 2025
·
8 min read
·
Annalee Armstrong
Bankruptcy
Bluebird’s Go-Private Deal Highlights Fraught Life Preserver for Struggling Biotechs
Facing declining valuations and funding challenges, public biotechs like bluebird bio are going private to restructure, reduce regulatory burdens and refocus on long-term growth.
March 12, 2025
·
6 min read
·
Ana Mulero
Business
Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024
Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 24, 2024.
April 1, 2024
·
1 min read
Legal
Novo Seeks $830M in Fraud Case Against Singaporean Biotech Over Kidney Drug
Back in 2023, Novo Nordisk committed up to $1.3 billion for a hypertension and kidney disease drug from KBP Biosciences. Now, the pharma giant claims to have been misled by the biotech’s founder—and a judge seems to agree.
February 18, 2025
·
1 min read
·
Annalee Armstrong
Business
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results
Mesa Laboratories, Inc., a global leader in the design and manufacture of life science tools and critical quality control solutions, announced results for its fourth fiscal quarter and fiscal year ended March 31, 2024.
June 5, 2024
·
22 min read
1 of 71,539
Next
